算力概念股午后走强，生益电子涨超18%，科创信息技术ETF摩根(588770)拉升涨近2%冲击3连涨

Group 1 - The core viewpoint of the news highlights the strong performance of the Science and Technology Innovation Information Technology ETF Morgan (588770), which has seen a 1.71% increase, marking a three-day consecutive rise, driven by significant gains in constituent stocks such as Shengyi Electronics (688183) and Chipone Technology (688521) [1] - The Science and Technology Innovation Information Technology ETF Morgan has experienced a notable increase in scale and shares, with a growth of 2.8431 million yuan in the past week and an increase of 3 million shares, leading among comparable funds [1] - The Chinese public cloud market is returning to double-digit growth driven by generative AI, with a projected year-on-year growth of 15.8% in the second half of 2024, and Alibaba Cloud leading the IaaS and PaaS markets with market shares of 26.1% and 24.4% respectively [1] Group 2 - The Science and Technology Innovation Information Technology Index tracks 50 large-cap companies in next-generation information networks, electronic core, emerging software, and new information technology services, reflecting the overall performance of the new generation information technology industry on the Science and Technology Innovation Board [2] - Morgan Asset Management is integrating its "Global Vision Investment Technology" product line to assist investors in seizing investment opportunities in quality technology companies globally, driven by the new wave of technology led by AI [2] - Various actively managed funds are focusing on emerging industry trends, including the Morgan Emerging Power Fund, which aims to capture trends in emerging industries, and the Morgan Smart Connectivity Fund, which focuses on AI-related opportunities [2] Group 3 - Passive investment options include the Morgan Hang Seng Technology ETF, which provides exposure to Hong Kong tech assets, and the Morgan Nasdaq 100 Index Fund, which offers access to global tech leaders [3] - The Morgan CSI Innovative Drug Industry ETF allows for investment in Chinese innovative pharmaceutical companies, showcasing a diverse range of passive investment products available to investors [3]